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Abstract: Background: Vitamin D insufficiency/deficiency prevalent in all age groups across the world is common in obesity and 
may play an important role in the risk factors of metabolic syndrome (MS).  Objectives: This cross-sectional study is to evaluate 
the relationship between levels of adiponectin and circulating 25(OH)D, and its effect on metabolic biomarker among 
overweight/obese female students.  Methods: Three hundred female students; with mean age 20.9 ± 3.2 years were attending the 
Aljouf University, Sakaka, Saudi Arabia. They were randomly selected from university during the studying year 2015 – 2016. 
Anthropometric and biochemical indices were determined. Results: The study showed 19% of the female’s student were either 
overweight or obese (15% and 4%, respectively). The frequency of MS diagnosis among the students was 17%, with 13% and 4% 
had either three or four risk factors, respectively. Overweight/obese subjects had significantly worse anthropometric and 
biochemical characteristics, including waist/hip ratio, blood pressure (BP), fasting blood glucose (BG), insulin, insulin resistance 
(HOMA-IR), triglyceride levels (TG), low-density lipoprotein cholesterol levels (LDL-C), leptin, adiponectin, leptin/adiponectin 
ratio and high-density lipoprotein cholesterol levels (HDL-C) compared to normal weight. Of the subjects diagnosed with MS, 
59% had mild and 8.6% had severe 25(OH)D deficiency. There was negative association between 25(OH)D and both FBG and 
HOMA-IR among young women obese/overweight. Conclusion: In our study, it suggested that low level of adiponectin was 
strongly correlated with low 25(OH)D levels. Also, the prevalence of MS tends to increase with high occurrence rate of low 
circulating 25(OH)D levels that is, known cause poor glycemic control and prediction of cardiovascular outcomes. 
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1. INTRODUCTION 
Vitamin D insufficiency/deficiency is prevalent in all 
age groups across the world.  Vitamin D deficiency, which is 
deemed to occur at a low level of 25(OH)D in blood less 
than 50 mmol/l, is common in obese people[1]. Several 
studies have found serum 25(OH)D levels greater than 50 
nmol/l to be prevalent (in up to 90% of the population) with 
partial of < 25 nmol/l in South Asia, Middle East and North 
Africa[1]. Low vitamin D status which indicated by 
circulating 25(OH)D is linked to metabolic risk factors such 
as inflammation, adipokines, insulin resistance, 
abnormalities of lipid profile, and high (BP) in adults[2]. 
However, many studies have evaluated the relationship 
between 25(OH)D concentrations and metabolic components 
in children and adolescents. Some workers suggested that 
vitamin D is isolated in excess fatty tissue, resulting in lack 
of biological availability[3]. In a study of Pittas et al., found 
that individuals who suffered from CVD were more vitamin 
D deficient than those without CVD[4]. In a different study 
that followed young adults for more than 20 years, vitamin D 
level, in combination with vitamin D supplementation, was 
inversely related to the incidence of MS in the study 
population [5]. It also, suggested that lifestyle factors and 
having high levels of body fat mass might contribute to this 
development. Kayaniyil et al., reported 25(OH)D levels to be 
negatively correlated with the first and second phases of 
insulin secretion, and to be positively correlated with insulin 
sensitivity in type-2 diabetes[6].  
Adipokines secretes by adipose tissue, has a vital role on 
body weight, blood glucose, and lipid metabolism. 
Adiponectin, a collagen-like protein has anti-inflammatory, 
antiatherogenic and antidiabetic properties. Increased 
circulating of adiponectin is linked with reduced risk of 
impaired glucose tolerance, decreased myocardial infarction 
risk, and was suggest as indicator of atherosclerosis early 
[7]. In obesity, Adiponectin was declined and may be 
involved in type-2 diabetes and cardiovascular disease 
pathology [7]. Adipose tissues secrete leptin, a cytokine-like 
molecule that regulates the fatty mass and body weight by 
inhibiting eating and stimulating energy consumption [8]. 
Leptin was increases in obesity, type-2 diabetes, MS and 
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hypertension. Several studies have found that leptin is a 
biomarker of obesity, IR, MS and cardiovascular disease in 
adult[8].  
Hyperlipidaemia, which considered to be an 
independent CVD risk factor, forms a potential link between 
low vitamin D levels and CVD. Dyslipidaemia, known to be 
a disorder of lipoprotein metabolism, is the result of excess 
TG, TC, LDL-C, and is due to the suppression of HDL-C. A 
favourable serum lipid profile is correlated with high levels 
of 25(OH)D which regulates the appropriate use of 
apolipoprotein A-1 (ApoA1), since it is a component of HDL 
Salehpou et al.,[9] conducted a study on obese individuals 
who received vitamin D supplement (25μg/d); the results of 
this study suggested that significantly elevated levels of 
HDL-C and Apo A-1 lowered body fat in obese individuals. 
The objective of the current study was to evaluate the 
relationship between levels of adiponectin and circulating 
25(OH)D levels, and its effect on metabolic biomarker 
among overweight/obese female students who attending in 
Aljouf University, Sakaka, Saudi Arabia. 
2. METHODS   
Subjects 
This cross-sectional study, which took place between 
November 2015 and June 2016, was performed on group of 
300 overweight/obese female students; with mean age 
20.9±3.2 years. Subjects were selected randomly from 
female students attended in Al Jouf University, Sakaka, 
Saudi Arabia. They were excluded from the following 
criteria: liver disease, kidney disease, diabetes mellitus, use 
of any medication that could affect bone health or vitamin D 
status within the previous three years, history of pregnancy, 
lactation convulsions, thyroid-parathyroid diseases, adrenal 
disease, or gonadal disease. All participates gave their 
informed consent before inclusion in this study. The study 
was approved by the Medical Research Ethics Committee of 
the Faculty of Medicine, King Saud University. 
Data collection. Each subject completed a self-reporting 
questionnaire that revealed their socio-economic status, age, 
smoking habits, meal and snack frequencies, and level of 
physical activity, as well as the educational and occupational 
status of each of their parents . 
Dietary data.  For each subject, the following data were 
recorded: the frequency of meals and snacks, and daily intake 
of vegetables, fruits, fatty foods, sugars, milk, mushrooms, 
fish, and crustaceans. Lifestyle practices, such as physical 
activity (exercise) and history of vitamin D supplements, were 
also recorded. 
Nutrient analysis. Daily dietary intake was recorded over 
three consecutive days to insure energy and nutrient intake. A 
software program, purchased from ESHA[10], was used to 
analyse the nutritional content of each subject’s diet. The 
dietary reference intakes (DRI), which are the recommended 
dietary intakes for a healthy diet, were calculated for each 
subject, adjusting for local practices, gender, age, weight, 
height, and physical activity levels[11] 
Anthropometric measurements. Anthropometric data, 
including weight and height, were recorded (to the 
nearest0.1kg and0.5cm, respectively) using a beam balance 
scale (Adam Equipment Inc.,USA) after removal of outer 
garments and shoes; body mass index (BMI) was calculated 
(body weight/kg/(body height/ m)2)[12]. Body weight was 
categorised according to BMI values using the National 
Institutes of Health guidelines: (i) normal with BMI range 
18.5-24.9, (ii) overweight with BMI range 25.0-29.9, and (iii) 
obese with BMI > 30[13]. Waist and hip circumferences(cm) 
were measured and the weight-to-hip ratio(WHR) was 
calculated[14]. Systolic and diastolic blood pressures were 
recorded, using the average of two measurements that were 
taken within 15-minuts interval using standardised mercury 
sphygmomanometer. Subjects whose BP measurements were 
≥130/85mmHg were classified as being hypertensive[15]. 
Diagnostic criteria. MS was diagnosed when three or more of 
the following criteria: abdominal obesity (WC≥88 cm), 
elevated FBG (≥ 100 mg/dl or diagnosed with diabetes, or 
taking an oral hypoglycaemic or insulin medication), reduced 
HDL-C level (≤40 mg/dl), elevated TG level (≥150mg/dl) and 
elevated BP (SBP≥130 mmHg, DBP≥85 mmHg or taking 
antihypertensive medication)[16]. 
Biochemical analyses. Blood samples were drawn after 
fasting for more than 12-hrs and the serum was separated and 
frozen at -20°C. Glucose concentration was estimated using a 
commercially available glucose kit (Randox Laboratories Ltd., 
UK.) based on the glucose oxidase method. Serum TC, LDL-
C, HDL-C and TG, creatinine, uric acid, aspartate 
aminotransferase (AST) and alanine aminotransferase (ALT) 
activities were estimated colorimetrically using the available 
kits (cited in Randox Laboratories Ltd., UK). Serum 25(OH)D 
and insulin levels were measured by enzyme-linked 
immunosorbent assay (ELISA) (IDS, Tyne and Wear, UK). 
The inter- and intra-assay variabilities for 25(OH)D were 
5.2% and 4.3%, respectively, and the inter- and intra-assay 
variabilities for insulin were 5.7%, and 3.1%, respectively. 
Insulin resistance was calculated using HOMA-IR 
(insulin[mU/L] ×glucose[mg/dl]/405[17]. Serum adiponectin 
and leptin were measured by ELISA. the intra-assay and inter-
assay coefficients of variation for adiponectin was 5.4% and 
8.5% respectively and intra-assay and inter-assay coefficients 
of variation for leptin was 7.4% and 9.3% respectively (Ani 
Biotech Oy, Orgenium Laboratories Division, Vantaa, 
Finland). The reading was taken using an ELISA microplate 
reader (VERSA Max, Molecular Devices Corporation, MN, 
USA). Vitamin D status was classified as follows: (i) deficient 
(vitamin D levels < 20 ng/ml), (ii) insufficient (vitamin D 
levels in the range 20 – 29 ng/ml), and (iii) sufficient (vitamin 
D levels >30 ng/ml)[18]. 
Statistical Analysis. 
Data were expressed as mean ± standard deviation(SD) and 
data were analysed using SPSS version 12.0 software (SPSS, 
Chicago, III), using the appropriate statistical tests (chi-square 
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test, Student’s t-test, correlation coefficient, odds ratio). The P 
values were considered significant for P < 0.05. 
3. RESULTS 
Socio-demographic characteristics of the study group are 
described in Table 1. The mean age of the subjects was 20.9 ± 
3.2 years. The parents of the subjects had been educated to at 
least University standard in 66% (fathers) and 36% (mothers) 
of the cases. Most fathers (65%) were employed whereas few 
mothers (29%) were employed. Family history of MS was 
64%. The study showed 19% of the subjects were either 
overweight/obese (15% and 4%, respectively). The frequency 
of MS diagnosis of the subjects was 17%, with 13% and 4% 
of the subjects having three or four risk factors, respectively 
(Table 2).  
Anthropometric and biochemical characteristics of the 
subjects are detailed in Table 3. When compared to normal 
weight subjects, overweight\obese subjects had statistically 
significant of anthropometric and biochemical parameters. A 
higher levels of fasting blood glucose, insulin, HOMA-IR, 
leptin, leptin/adiponectin ratio, TG, LDL-C, W/H ratio, SBP 
and DBP in overweight/obese female students; but lower 
adiponectin and HDL-C levels. Also, overweight/obese 
subjects had significantly lower levels of 25(OH)D (p<0.01) 
relative to the normal weight.  
Fifty-nine percent of the students that were diagnosed as 
having MS had mild 25(OH)D deficiency and 8.56% had 
severe 25(OH)D deficiency (Table 5). Serum 25(OH)D 
levels were negatively associated with BMI, FBG, leptin, 
leptin/adiponectin ratio, LDL-C, TG and BP, and positively 
associated with adiponectin and HDL-C (P<0.01) (Table 6). 
In addition, MS had pronounced impact on elevating leptin 
and inhibition adiponectin levels that was additive to 
overweight/obesity. Otherwise, leptin/adiponectin ratio, that 
had postulated as a biomarker, was increased in subjects with 
MS than without. 
Table 7 details the association between MS and different risk 
factors. It can be observed that the primary predisposing risk 
factor for MS was abdominal obesity (OR 5.92). The second 
predisposing risk factor for MS was abdominal obesity, as 
indicated by WC (OR 5.26), followed by leptin (OR 4.84), 
Leptin/adiponectin ratio (OR 4.73), adiponectin (4.26), 
hypertension (OR 4.11), low HDL-C (OR 3.42), FBG (OR 
3.11) and vitamin 25(OH)D (OR 2.87). 
The levels of carbohydrates and sugar consumption were 
significantly higher in subjects with MS compared to those 
without (Table 8). Consumption of dietary saturated fats 
were significantly more by subjects with MS than those 
without, but dietary fibre was consumed significantly less 
among subjects with MS than those without. 
In overweight/obese, the daily dietary intake of vitamin D 
was 198±136.6 IU/day and in normal weight was 190±129.6 
IU/day. The intake of vitamin D as a percental of DRI was 
101.0±69.2% in overweight/obese subjects and 89.9±49.8% 
in normal subjects. Among the groups study, no statistically 
significant in vitamin D intake was showed either based on 
daily intake or on the percent of DRI.  
4. DISCUSSION  
Vitamin D has a vital role of public health and human well-
beings and its deficiency has been linked to several 
metabolic disorders including Cancer, autoimmune diseases, 
obesity, type-2 diabetes, hypertension and cardiovascular 
disease and there is a relationship between low serum 
25(OH)D, HOMA-IR, type-2 diabetes and low adiponectin 
in adults[19]. In the finding Leptin was increased and 
adiponectin decreased in overweight/obese female students 
relative to normal weight. There was a strong correlation 
between leptin with abdominal obesity and inverse to 
adiponectin. Furthermore, leptin, leptin-to-adiponectin ratio 
and adiponectin were strongly correlated with MS. These 
results had additive effects to overweight/obesity among 
female students. The most important outcomes are the 
combination of risk factors with increased leptin or lack of 
adiponectin that was found in overweight/obesity among 
female students. A cross-sectional study by lee et al., 
conducted on adolescents aged 12–19 years showed that 
abdominal obesity was the predominate risk factor for IR 
and there is an inverse correlation between adiponectin and 
obesity and IR which is linked to risk factors of cardiac 
disease[20].  
The results of our study showed that low serum 25(OH)D 
associated with abdominal obesity, adiponectin, HOMA-IR 
as well as leptin/adiponectin ratio. Leptin and adiponectin 
have adverse effects on inflammation and insulin resistance, 
the high level of leptin increases the expression of pro-
inflammatory and vasoconstrictive factors[21]; while 
adiponectin stimulates anti-inflammatory cytokines 
production and enhanced the sensitivity of peripheral 
insulin[22]. Al-Daghri et al., observed that a positive 
correlation between BMI and; 25(OH)D and adiponectin in 
type-2 diabetes. The fact is that these adipokines has a 
potential role as a link between 25(OH)D and IR[23]. 
The current study showed 25(OH)D levels to be significantly 
lower in subjects who had been diagnosed with MS 
compared to those without MS. The finding also, observed 
that subjects who had been diagnosed with MS were mildly 
25(OH)D deficient more frequently than those without. 
Additionally, vitamin D deficiency was more prevalent in 
obese subjects who had been diagnosed with MS(60.9%) 
compared to obese subjects without (33.3%). Previous 
studies have elucidated an inverse association between serum 
25(OH)D levels and MS[24].
 
A cross-sectional study of 101 
healthy subjects living in urban areas found a risk of MS 
increases three-fold in subjects with low levels of vitamin D 
(23.37% vs. 8.3% P<0.001)[24].
 
   
Interestingly, after ameliorating lifestyle intervention in 
children obese /adults, adiponectin is the most predictive 
indicator for improving metabolic disorder, while changes in 
leptin were not related to positive metabolic outcomes[25]. 
However, the clustering of many unfavorable biomarkers 
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strongly requires early intervention not only in childhood 
obesity, but also in normal weight of subjects whose feature 
appear the risk. 
The underlying mechanisms of the association between 
25(OH)D status and dyslipidaemia are poorly understood. 
Previous studies have demonstrated that being either 
overweight/ obese was strongly associated with 
dyslipidaemia (elevated TG and lower HDL-C) in Asian-
Indian adolescents living in urban area[26].
 
In the third 
National Health and Nutrition Examination Survey[26], 
adults whose 25(OH)D level was in the lowest quartile had 
the highest risk of elevated serum TG levels (≥150 mg/dl); 
this demonstrates that the health dangers of low vitamin D 
levels. Similarly, in obese subjects, 25(OH)D levels below 
50 nmol/l were associated with lower HDL-C and high TG 
levels[27].
 
In the present study, it was observed that the level 
of 25(OH)D was positively correlated with HDL‐C (P< 
0.01) and negatively correlated with TG levels and LDL-C 
(P<0.05). The female students in our study who had been 
diagnosed with MS had significantly elevated levels of TC, 
LDL‐C, TG and BP, and significantly reduced levels of 
HDL‐C compared to those without MS. Several 
epidemiological studies found that serum 25(OH)D levels to 
be negatively associated with BMI[28,29]; excessive weight 
is a major component of MS, which may be attributed to 
lower 25(OH)D levels. However, in a cross-sectional study 
conducted on children, it was found that there is a negative 
correlation between 25(OH)D and BMI, FBG, LDL-C and 
TG, and positive correlation with HDL-C (P<0.01)[29].  
Insulin resistance is strongly associated with obesity and 
type-2 diabetes, hypertension, hyperlipidaemia and 
CVD[30]. There is evidence from both clinical and non-
clinical studies that glucose homeostasis might affect the 
level of vitamin D[30]. In pervious study that focussed on 
pancreatic β-cells and the effect of vitamin D receptors, it 
was found that glucose intolerance, impaired synthesis and 
secretion of insulin, as well as an increased risk of type-2 
diabetes, may be affected by insufficient 25(OH)D 
levels[31]. Peterson et al., found that vitamin D deficiency 
is associated with different metabolic disorders, and the 
authors concluded that low levels of vitamin D is a risk 
factor for MS[31]. Our findings illustrated that significant 
increased odds ratio between high levels of TC, TG and 
LDL-C in subjects that had serum 25(OH)D levels below 20 
ng/ml when compared to subjects that had normal serum 
25(OH)D levels. The lower levels of 25(OH)D may be 
attributed to poor dietary intake of vitamin D as well as 
insufficient exposure to sunlight, despite the strong natural 
light of Saudi Arabia.  
Considering the associations between MS and different 
predisposing factors, the finding found that obesity was the 
strongest predisposing risk factor for MS (OR:5.92). The 
second strongest predisposing risk factor for MS was 
abdominal obesity (OR:4.26). Unsurprisingly, WC, which is 
typically used as a surrogate measure of abdominal obesity, 
is the main criteria when determining MS risk. We also, 
found that the hypertension to be a strong risk factor for MS 
(OR:4.11); this similar with a study by Co et al who reported 
that hypertension (SBP & DBP) was the strongest 
predisposing risk factor with MS [32]
. Previous studies of 
children living in urban areas have demonstrated that obesity 
is a major risk factor in the development of childhood 
hypertension[33]. In addition, we found that lifestyle is a risk 
factor for MS, with OR of 2.87. previous scientists indicated 
that regular physical activity and eating healthy diet have 
positive influence on health status, reducing the risk of 
obesity and thus reducing the risk of cardiac disease[29]. 
While elevated blood lipid levels increase the risk of 
hypertension, increasing physical activity lowers that risk; 
this is because exercise increases energy requirements and 
decreases fat deposition[34]. Bombak [35] found the 
prevalence of obesity to be increased by eating calorie dense 
food and failing to take adequate exercise While MS can be 
treated, in part, pharmacologically, the most important 
strategy for reducing the risk of MS and heart disease is to 
make lifestyle changes that promote physical activity and 
reduce excess weight.
 
An analyses of macronutrients showed that the consumption 
of carbohydrates and sugar were significantly higher in 
subjects with MS compared to those without MS, Whereas 
subjects with MS consumed less dietary fibre than without 
MS. Rapid changes in contemporary lifestyle habits can be 
seen in Saudi Arabia that are contributing to (i) increased 
consumption of foods that are high in carbohydrates and 
sugars, and (ii) lack of adequate physical activity; the 
combined result of these lifestyle changes is an increase the 
prevalence of MS in the Saudi Arabian population[36]. 
These results are consistent with studies that found sedentary 
lifestyle and poor dietary habits to be important predictors 
for development of MS[36].  
5. CONCLUSION 
In our study, it suggested that low level of adiponectin was 
strongly correlated with low 25(OH)D levels. Also, the 
prevalence of MS tends to increase with the high occurrence 
rate of low circulating 25(OH)D levels that is, known cause 
poor glycemic control. This relationship is unclear and may 
be a sign of future prediction of cardiovascular outcomes. 
Further studies are needed in the young population who are 
overweight/obese to assess the relationship between 
circulating adiponectin levels, low 25(OH)D and IR for 
adverse cardiovascular and metabolic outcomes. We suggest 
requiring strategies efforts to prevent the tendency of 
deficiency and should be improved in early and middle age 
by increasing outdoor physical activity and by strengthening 
dietary vitamin D in the diet part of the Saudi diet.  
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